Mai Capital Management First Trust Nyse Arca Biotechn Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Mai Capital Management holds 7,411 shares of FBT stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,411

Previous 7,973 7.05%

Holding current value

$1.23 Million

Previous $1.23 Million 3.83%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$152.39 - $172.91 $85,643 - $97,175	-562 Reduced 7.05%	7,411 $1.27 Million
Q1 2024 May 08, 2024	SELL	$145.08 - $160.46 $43,088 - $47,656	-297 Reduced 3.59%	7,973 $1.23 Million
Q4 2023 Feb 09, 2024	SELL	$132.5 - $158.45 $198,750 - $237,674	-1,500 Reduced 15.35%	8,270 $1.31 Million
Q3 2023 Nov 14, 2023	SELL	$145.69 - $157.89 $90,327 - $97,891	-620 Reduced 5.97%	9,770 $1.43 Million
Q2 2023 Aug 02, 2023	BUY	$151.19 - $159.79 $79,223 - $83,729	524 Added 5.31%	10,390 $1.59 Million
Q1 2023 May 10, 2023	SELL	$147.92 - $165.37 $12,129 - $13,560	-82 Reduced 0.82%	9,866 $1.53 Million
Q4 2022 Feb 09, 2023	SELL	$132.87 - $159.04 $56,469 - $67,592	-425 Reduced 4.1%	9,948 $1.53 Million
Q3 2022 Nov 15, 2022	SELL	$128.6 - $149.75 $128 - $149	-1 Reduced 0.01%	10,373 $1.37 Million
Q2 2022 Jul 19, 2022	BUY	$123.32 - $155.54 $749,785 - $945,683	6,080 Added 141.59%	10,374 $1.41 Million
Q1 2022 May 10, 2022	SELL	$137.27 - $163.07 $2,059 - $2,446	-15 Reduced 0.35%	4,294 $640,000
Q4 2021 Feb 11, 2022	BUY	$153.09 - $169.84 $659,664 - $731,840	4,309 New	4,309 $698,000

Others Institutions Holding FBT

# of Institutions

269

Shares Held

3.61M

Call Options Held

25.5K

Put Options Held

View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

More about FBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management First Trust Nyse Arca Biotechn Transaction History